Photo illustration: Lindsey Bailey/Axios. Photo: Abridge
Axios spoke with Abridge CEO Shiv Rao about the company's approach to clinical documentation and what's next for AI scribe companies.
Why it matters: Abridge has raised $212.5 million and was valued at $850 million in February 2024.